New Consortium Launches Colorado Hub for Health Impact, a National Economic Development Campaign to Attract Health Innovation Companies to the State    

For Immediate Release: February 27, 2024 NEWS RELEASE 20+ Life Sciences Organizations, Economic Development Groups, Local Governments, Developers, and Builders Invest to Bring New, High-Growth Compani...

Learn More

Weekly Policy Blog: CBSA Talks PDAB at CSBA Summit; PDAB Ad Campaign & Media Highlight 

Amy Goodman, CBSA’s Vice President & Counsel for Policy + Advocacy, attended the 2023 Annual Council of State Bioscience Associations (CSBA) Summit in New Orleans this past week and discussed Colo...

Learn More

Fitzsimons Innovation Community and Aimco Host Media Event Focused on Sharing Momentum, Trends, and Patient-Impact Storylines

With Aimco, Fitzsimons Innovation Community hosted members of the local and national media to learn firsthand about breakthrough work from 10 of the 80+ visionary biotech and life sciences companies i...

Learn More

Weekly Policy Blog: CBSA Joins New Partnership to Promote Benefits of Pro-Innovation Mergers & Acquisitions 

CBSA has joined a new coalition to raise awareness of the fundamental role of pro-innovation mergers and acquisitions (M&A) in advancing the next generation of treatments and cures for patients. P...

Learn More

Rockies Venture Club: Three Myths of Life Science Angel Investing

By Rockies Venture Club | RVC Weekly Newsletter July 3 The Three Fallacies of Life Science Investing I'm always interested to see how angels and angel groups present themselves to the public with rega...

Learn More

PMB and Montgomery Street Partners announce approval on the first speculative purpose-built life sciences project in Boulder County, CO

This new 365,000 sq. ft. facility in Boulder County will break ground in Q2 of 2023 and complete in Q3 of 2024 PMB, a leading healthcare real estate developer, in partnership with Montgomery Street Pa...

Learn More

Think Bioscience Raises $17M in Oversubscribed Seed Round to Develop Small Molecule Drugs that Hit Undruggable Proteins

Funding will enable Think Bioscience to expand its drug discovery platform and advance its internal drug development programs.  Think Bioscience (“Think”), a synthetic biology company focuse...

Learn More

HepQuant Awarded COLA Accreditation for meeting US Clinical Laboratory Improvement Act (CLIA) and other Regulatory Requirements

HepQuant, LLC,  a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced that the HepQuan...

Learn More

AGC Biologics Supports Altheia Science’s Gene Therapy Programs

AGC Biologics, today, announced a new partnership with Altheia Science. Through this partnership, Altheia Science will advance its development of autoimmunity treatments, focused on modulati...

Learn More

Terumo Blood and Cell Technologies collaborates with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialy...

Learn More